The findings, presented at this years European Congress on Obesity in Istanbul, Turkey, which took place in May 2026, showed that treatment with GLP-1 receptor agonists was associated with a 26 per cent reduction in the rate of asthma exacerbations and a 14 per cent reduction in the use of inhaled short-acting 2-agonist reliever medication, such as salbutamol
You should not use this medication if you have a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)
Because peptides influence biological signaling pathways, improper use may create unintended effects
If a company quotes that trial on its label, but the product supplies half the trial dose, real-world results are unlikely to match the studys headline numbers
Patients and healthcare professionals in these situations should liaise directly with the relevant clinical trial team or specialist, and follow local clinical policies